Publication | Open Access

Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial

Surgical OncologyMedicinePathologyAdvanced Solid TumoursImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology